ArticleScientific reports2021

First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis.

Nuria Tubau-Juni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.